Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Wahrmann

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Opinion in Organ Transplantation|August 8, 2008
Antibodies, isotypes and complement in allograft rejectionGeorg A Böhmig, Gregor Bartel, Markus Wahrmann
Current Opinion in Organ Transplantation|October 6, 2011
Transplantation of the broadly sensitized patient: what are the options?Georg A Böhmig, Markus Wahrmann, Gregor Bartel
Molecular Diagnosis & Therapy|February 4, 2010
Detecting adaptive immunity: applications in transplantation monitoringGeorg A Böhmig, Markus Wahrmann, Marcus D Säemann
Transplantation|June 6, 2018
Novel Approaches to Block ComplementGeorg A Böhmig, Markus Wahrmann, Farsad Eskandary, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 18, 2015
Complement inhibition as potential new therapy for antibody-mediated rejectionFarsad Eskandary, Markus Wahrmann, Jakob Mühlbacher, et al.
Human Immunology|April 21, 2009
Prospects and limitations of post-transplantation alloantibody detection in renal transplantationGeorg A Böhmig, Gregor Bartel, Heinz Regele, et al.
Transplantation|March 14, 2014
Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beadsElisabeth Schwaiger, Markus Wahrmann, Gregor Bond, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2022
Massive release of T<sub>H</sub>2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosisThomas Boehm, Robin Ristl, Jakob Mühlbacher, et al.
Transplantation|April 17, 2010
C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejectionGideon Hönger, Markus Wahrmann, Patrizia Amico, et al.
Human Immunology|June 7, 2005
[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodiesMarkus Wahrmann, Markus Exner, Bettina Haidbauer, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Opinion in Organ Transplantation|August 8, 2008
Antibodies, isotypes and complement in allograft rejectionGeorg A Böhmig, Gregor Bartel, Markus Wahrmann
Current Opinion in Organ Transplantation|October 6, 2011
Transplantation of the broadly sensitized patient: what are the options?Georg A Böhmig, Markus Wahrmann, Gregor Bartel
Molecular Diagnosis & Therapy|February 4, 2010
Detecting adaptive immunity: applications in transplantation monitoringGeorg A Böhmig, Markus Wahrmann, Marcus D Säemann
Transplantation|June 6, 2018
Novel Approaches to Block ComplementGeorg A Böhmig, Markus Wahrmann, Farsad Eskandary, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 18, 2015
Complement inhibition as potential new therapy for antibody-mediated rejectionFarsad Eskandary, Markus Wahrmann, Jakob Mühlbacher, et al.
Human Immunology|April 21, 2009
Prospects and limitations of post-transplantation alloantibody detection in renal transplantationGeorg A Böhmig, Gregor Bartel, Heinz Regele, et al.
Transplantation|March 14, 2014
Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beadsElisabeth Schwaiger, Markus Wahrmann, Gregor Bond, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2022
Massive release of T<sub>H</sub>2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosisThomas Boehm, Robin Ristl, Jakob Mühlbacher, et al.
Transplantation|April 17, 2010
C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejectionGideon Hönger, Markus Wahrmann, Patrizia Amico, et al.
Human Immunology|June 7, 2005
[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodiesMarkus Wahrmann, Markus Exner, Bettina Haidbauer, et al.
Pageof 7